This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Stephen E. Harrigan: Inventor in Schizophrenia Treatment
Introduction
Stephen E. Harrigan is an inventor associated with Ann Arbor, Michigan, and Warner-Lambert Company. His patent work concerns a proposed approach to treating schizophrenia while reducing the risk of certain neurological side effects.
Latest Patents
Harrigan is credited with 1 patent, titled “Method for Treating Schizophrenia and Medicaments Therefor.” The patent describes administering a diphenylalkyladenosine or diphenylalkyl-2-amino-adenosine before or alongside haloperidol. The stated aim is to treat schizophrenia without precipitating neurological side effects such as extrapyramidal syndrome and tardive dyskinesia. It also describes pharmaceutical compositions for this treatment approach.
Career Highlights
Harrigan’s listed patent is associated with Warner-Lambert Company. It reflects work on pharmaceutical methods and compositions intended to address both treatment and side-effect concerns.
Collaborations
Harrigan’s listed coworkers include Jerry A. Weisbach and Thomas Gary Heffner.
Conclusion
Stephen E. Harrigan’s patent record highlights a pharmaceutical approach to schizophrenia treatment designed to reduce the risk of specific neurological side effects.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile